Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke.

Åberg D, Jood K, Blomstrand C, Jern C, Nilsson M, Isgaard J, Aberg ND.

J Clin Endocrinol Metab. 2011 Jul;96(7):E1055-64. doi: 10.1210/jc.2010-2802. Epub 2011 Apr 20.

PMID:
21508132
2.

Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome.

Bondanelli M, Ambrosio MR, Onofri A, Bergonzoni A, Lavezzi S, Zatelli MC, Valle D, Basaglia N, degli Uberti EC.

J Clin Endocrinol Metab. 2006 Oct;91(10):3928-34. Epub 2006 Aug 1.

PMID:
16882751
3.

Insulin-like growth factor I serum levels influence ischemic stroke outcome.

De Smedt A, Brouns R, Uyttenboogaart M, De Raedt S, Moens M, Wilczak N, Luijckx GJ, De Keyser J.

Stroke. 2011 Aug;42(8):2180-5. doi: 10.1161/STROKEAHA.110.600783. Epub 2011 Jun 23.

4.

Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.

Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR, Ceda GP.

Am J Med. 2004 Sep 1;117(5):312-7.

PMID:
15336580
5.

Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke.

Ebinger M, Ipsen N, Leonards CO, Empl L, Hanne L, Liman T, Mai K, Strasburger CJ, Spranger J, Endres M.

Exp Clin Endocrinol Diabetes. 2015 Sep;123(8):461-5. doi: 10.1055/s-0035-1554632. Epub 2015 Jun 11.

PMID:
26069074
6.

Insulin-like growth factor-1 as a prognostic marker in patients with acute ischemic stroke.

Tang JH, Ma LL, Yu TX, Zheng J, Zhang HJ, Liang H, Shao P.

PLoS One. 2014 Jun 9;9(6):e99186. doi: 10.1371/journal.pone.0099186. eCollection 2014.

7.

Genetic variation at the IGF1 locus shows association with post-stroke outcome and to circulating IGF1.

Aberg ND, Olsson S, Aberg D, Jood K, Stanne TM, Nilsson M, Blomstrand C, Svensson J, Isgaard J, Jern C.

Eur J Endocrinol. 2013 Oct 21;169(6):759-65. doi: 10.1530/EJE-13-0486. Print 2013 Dec.

8.

Changes in serum growth factors in stroke rehabilitation patients and their relation to hemiparesis improvement.

Okazaki H, Beppu H, Mizutani K, Okamoto S, Sonoda S.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1703-8. doi: 10.1016/j.jstrokecerebrovasdis.2014.01.015. Epub 2014 Apr 24.

PMID:
24768137
9.

Osteopontin predicts long-term functional outcome among ischemic stroke patients.

Mendioroz M, Fernández-Cadenas I, Rosell A, Delgado P, Domingues-Montanari S, Ribó M, Penalba A, Quintana M, Alvarez-Sabín J, Montaner J.

J Neurol. 2011 Mar;258(3):486-93. doi: 10.1007/s00415-010-5785-z. Epub 2010 Oct 22.

PMID:
20967551
10.

Serum uric acid and outcome after acute ischemic stroke: PREMIER study.

Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Orozco-Valera DR, Ochoa-Guzmán A, Villarreal-Careaga J, León-Jiménez C, Barinagarrementeria F, Ramos-Moreno A, Cantú-Brito C.

Cerebrovasc Dis. 2013;35(2):168-74. doi: 10.1159/000346603. Epub 2013 Feb 22.

PMID:
23446426
11.

The relationship between serum insulin-like growth factor I levels and ischemic stroke risk.

Dong X, Chang G, Ji XF, Tao DB, Wang YX.

PLoS One. 2014 Apr 11;9(4):e94845. doi: 10.1371/journal.pone.0094845. eCollection 2014.

12.

Lack of association between serum uric acid levels and outcome in acute ischemic stroke.

Miedema I, Uyttenboogaart M, Koch M, Kremer B, de Keyser J, Luijckx GJ.

J Neurol Sci. 2012 Aug 15;319(1-2):51-5. doi: 10.1016/j.jns.2012.05.019. Epub 2012 May 26.

PMID:
22633441
14.

Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism.

Akhoundi FH, Ghorbani A, Soltani A, Meysamie A.

Neurology. 2011 Jul 26;77(4):349-54. doi: 10.1212/WNL.0b013e3182267ba0. Epub 2011 Jun 29.

PMID:
21715712
15.

Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.

J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.

PMID:
11061530
16.

Impaired cardiac performance in elderly patients with growth hormone deficiency.

Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.

J Clin Endocrinol Metab. 1999 Nov;84(11):3950-5.

PMID:
10566633
17.

Plasma homocysteine level and functional outcome of patients with ischemic stroke.

Mizrahi EH, Fleissig Y, Arad M, Adunsky A.

Arch Phys Med Rehabil. 2005 Jan;86(1):60-3.

PMID:
15640990
18.

A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.

Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2000 Jan;85(1):183-92.

PMID:
10634385
19.

Association of serum bilirubin with ischemic stroke outcomes.

Pineda S, Bang OY, Saver JL, Starkman S, Yun SW, Liebeskind DS, Kim D, Ali LK, Shah SH, Ovbiagele B.

J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):147-52. doi: 10.1016/j.jstrokecerebrovasdis.2008.01.009.

20.
Items per page

Supplemental Content

Write to the Help Desk